Literature DB >> 18373089

How does imaging help the clinician in the evaluation and management of spondyloarthritis?

Ulrich Weber1, Walter P Maksymowych.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18373089     DOI： 10.1007/s00256-008-0477-9

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  25 in total

1.  Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.

Authors:  X Baraliakos; J Brandt; J Listing; H Haibel; H Sörensen; M Rudwaleit; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2005-12-15

2.  Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study.

Authors:  Jürgen Braun; Robert Landewé; Kay-Geert A Hermann; John Han; Songkai Yan; Paul Williamson; Désirée van der Heijde
Journal:  Arthritis Rheum       Date:  2006-05

3.  Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.

Authors:  U Blum; C Buitrago-Tellez; A Mundinger; T Krause; J Laubenberger; P Vaith; H H Peter; M Langer
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

4.  Very early spondyloarthritis: where the inflammation in the sacroiliac joints starts.

Authors:  M Bollow; K-G A Hermann; T Biedermann; J Sieper; M Schöntube; J Braun
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

5.  Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic.

Authors:  L Heuft-Dorenbosch; R Landewé; R Weijers; H Houben; S van der Linden; P Jacobs; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2006-07-25       Impact factor: 19.103

6.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

7.  Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?

Authors:  A van Tubergen; L Heuft-Dorenbosch; G Schulpen; R Landewé; R Wijers; D van der Heijde; J van Engelshoven; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

8.  Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Robert G W Lambert; David Salonen; Proton Rahman; Robert D Inman; Robert L Wong; Steven G Einstein; Glen T D Thomson; Andre Beaulieu; Denis Choquette; Walter P Maksymowych
Journal:  Arthritis Rheum       Date:  2007-12

9.  Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis.

Authors:  Heiner Appel; Christoph Loddenkemper; Zarko Grozdanovic; Harald Ebhardt; Marc Dreimann; Axel Hempfing; Harald Stein; Peter Metz-Stavenhagen; Martin Rudwaleit; Joachim Sieper
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis.

Authors:  Ulrich Weber; Christian W A Pfirrmann; Rudolf O Kissling; Juerg Hodler; Marco Zanetti
Journal:  BMC Musculoskelet Disord       Date:  2007-02-27       Impact factor: 2.362
View more
  2 in total

1.  Diagnostic utility of MRI in early spondyloarthritis.

Authors:  Walter P Maksymowych; Ulrich Weber
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

2.  Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.

Authors:  Eiman Soliman; W Labib; G el-Tantawi; A Hamimy; A Alhadidy; A Aldawoudy
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.